Effects of curcumin on glucose metabolism in the brains of rats subjected to chronic unpredictable stress: A 18 F-FDG micro-PET study

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Lin, Zheng ^a   Shi, Ligen ^b   Lu, Jing ^b   Li, Jinhui ^a   Hu, Hua ^c   Zuo, Chuantao ^d   Tang, Weijun ^d   Lu, Yunrong ^a   Bao, Aimin ^b   Xu, Lei ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SOOCHOW UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE; SUCROSE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN METABOLISM; CHRONIC STRESS; CHRONIC UNPREDICTABLE STRESS; CONTROLLED STUDY; DEPRESSION; ELECTROENCEPHALOGRAM; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; MICRO POSITRON EMISSION TOMOGRAPHY; NEUROIMAGING; NONHUMAN; OPEN FIELD TEST; POSITRON EMISSION TOMOGRAPHY; PRIMARY AUDITORY CORTEX; RAT; REARING; RIGHT HEMISPHERE; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 84880957796     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-202     Document Type: Article

References (38)

1. Holden C. Mental health: global survey examines impact of depression. Science 2000, 288:39-40. 10.1126/science.288.5463.39, 10766633.
2. Saveanu RV, Nemeroff CB. Etiology of depression: genetic and environmental factors. Psychiatr Clin North Am 2012, 35:51-71. 10.1016/j.psc.2011.12.001, 22370490.
3. Kulkarni SK, Dhir A. An overview of curcumin in neurological disorders. Indian J Pharm Sci 2010, 72:149-154. 10.4103/0250-474X.65012, 2929771, 20838516.
4. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000, 48:813-829. 10.1016/S0006-3223(00)01020-9, 11063977.
5. Hirvonen J, Hietala J, Kajander J, Markkula J, Rasi-Hakala H, Salminen JK, Nagren K, Aalto S, Karlsson H. Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C] raclopride PET. J Psychopharmacol 2011, 25:1329-1336. 10.1177/0269881110376691, 20829308.
6. Kulkarni S, Dhir A, Akula KK. Potentials of curcumin as an antidepressant. Sci World J 2009, 9:1233-1241.
7. Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology 2008, 201:435-442. 10.1007/s00213-008-1300-y, 18766332.
8. Wang R, Xu Y, Wu HL, Li YB, Li YH, Guo JB, Li XJ. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur J Pharmacol 2008, 578:43-50. 10.1016/j.ejphar.2007.08.045, 17942093.
9. Sanmukhani J, Anovadiya A, Tripathi CB. Evaluation of antidepressant like activity of curcumin and its combination with fluoxetine and imipramine: an acute and chronic study. Acta Pol Pharm 2011, 68:769-775.
10. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol, Biochem Behav 2005, 82:200-206.
11. Bhutani MK, Bishnoi M, Kulkarni SK. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol, Biochem Behav 2009, 92:39-43.
12. Lin TY, Lu CW, Wang CC, Wang YC, Wang SJ. Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: possible relevance to its antidepressant mechanism. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1785-1793. 10.1016/j.pnpbp.2011.06.012, 21741425.
13. Huang Z, Zhong XM, Li ZY, Feng CR, Pan AJ, Mao QQ. Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats. Neurosci Lett 2011, 493:145-148. 10.1016/j.neulet.2011.02.030, 21334417.
14. Dvivedi J, Pandey S, Gupta R. Effect of curcumin on glucose absorption: an experimental study on albino rats. Indian J Physiol Pharmacol 2011, 55:207-212.
15. Hu H, Su L, Xu YQ, Zhang H, Wang LW. Behavioral and [F-18] fluorodeoxyglucose micro positron emission tomography imaging study in a rat chronic mild stress model of depression. Neuroscience 2010, 169:171-181. 10.1016/j.neuroscience.2010.04.057, 20435098.
16. Sung KK, Jang DP, Lee S, Kim M, Lee SY, Kim YB, Park CW, Cho ZH. Neural responses in rat brain during acute immobilization stress: a [F-18] FDG micro PET imaging study. Neuro Image 2009, 44:1074-1080.
17. Hill MN, Hellemans KG, Verma P, Gorzalka BB, Weinberg J. Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev 2012, 36:2085-2117. 10.1016/j.neubiorev.2012.07.001, 22776763.
18. Grippo AJ. Mechanisms underlying altered mood and cardiovascular dysfunction: the value of neurobiological and behavioral research with animal models. Neurosci Biobehav Rev 2009, 33:171-180. 10.1016/j.neubiorev.2008.07.004, 2593749, 18703084.
19. Xu Y, Ku B, Tie L, Yao H, Jiang W, Ma X, Li X. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res 2006, 1122:56-64. 10.1016/j.brainres.2006.09.009, 17022948.
20. Chen XN, Meng QY, Bao AM, Swaab DF, Wang GH, Zhou JN. The involvement of retinoic acid receptor-alpha in corticotropin-releasing hormone gene expression and affective disorders. Biol Psychiatry 2009, 66:832-839. 10.1016/j.biopsych.2009.05.031, 19596122.
21. Grippo AJ, Sullivan NR, Damjanoska KJ, Crane JW, Carrasco GA, Shi J, Chen Z, Garcia F, Muma NA, Van de Kar LD. Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology 2005, 179:769-780. 10.1007/s00213-004-2103-4, 15619113.
22. Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, Phelps ME, Weber WA. Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med 2006, 47:999-1006.
23. Schweinhardt P, Fransson P, Olson L, Spenger C, Andersson JL. A template for spatial normalisation of MR images of the rat brain. J Neurosci Methods 2003, 129:105-113. 10.1016/S0165-0270(03)00192-4, 14511814.
24. Stanford SC. The open field test: reinventing the wheel. J Psychopharmacol 2007, 21:134-135. 10.1177/0269881107073199, 17329288.
25. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110. 10.1159/000087097, 16037678.
26. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992, 16:525-534. 10.1016/S0149-7634(05)80194-0, 1480349.
27. Hecht D. Depression and the hyperactive right-hemisphere. Neurosci Res 2010, 68:77-87. 10.1016/j.neures.2010.06.013, 20603163.
28. Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F, Niehaus L, Boeker H, Northoff G. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry 2008, 63:369-376. 10.1016/j.biopsych.2007.05.033, 17888408.
29. Janocha A, Pilecki W, Bolanowski M, Malyszczak K, Salomon E, Laszki-Szczachor K, Kalka D, Sebzda T, Sobieszczanska M. Interhemispheric cerebral asymmetry detected by VEPS in diabetic patients with recognized depression. Neuro Endocrinol Lett 2009, 30:119-124.
30. Murray EA, Wise SP, Drevets WC. Localization of dysfunction in major depressive disorder: prefrontal cortex and amygdala. Biol Psychiatry 2011, 69:e43-e54. 10.1016/j.biopsych.2010.09.041, 3058124, 21111403.
31. Bigos KL, Pollock BG, Aizenstein HJ, Fisher PM, Bies RR, Hariri AR. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 2008, 33:3221-3225. 10.1038/npp.2008.52, 2858321, 18463627.
32. Drevets WC. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 2003, 985:420-444.
33. Applegate CD, Kapp BS, Underwood MD, McNall CL. Autonomic and somatomotor effects of amygdala central N. stimulation in awake rabbits. Physiol Behav 1983, 31:353-360. 10.1016/0031-9384(83)90201-9, 6635005.
34. Oliva J, Leung S, Croft RJ, O'Neill BV, O'Kane J, Stout J, Phan KL, Nathan PJ. The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission. Hum Psychopharmacol 2010, 25:423-427. 10.1002/hup.1133, 20589921.
35. Scarpidis U, Madnani D, Shoemaker C, Fletcher CH, Kojima K, Eshraghi AA, Staecker H, Lefebvre P, Malgrange B, Balkany TJ, Van De Water TR. Arrest of apoptosis in auditory neurons: implications for sensorineural preservation in cochlear implantation. Otol Neurotol 2003, 24:409-417. 10.1097/00129492-200305000-00011, 12806293.
36. Baxter LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM. Cerebral metabolic rates for glucose in mood disorders: studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry 1985, 42:441-447. 10.1001/archpsyc.1985.01790280019002, 3872649.
37. Lesser IM, Mena I, Boone KB, Miller BL, Mehringer CM, Wohl M. Reduction of cerebral blood flow in older depressed patients. Arch Gen Psychiatry 1994, 51:677-686. 10.1001/archpsyc.1994.03950090009002, 8080344.
38. Curran SM, Murray CM, Van Beck M, Dougall N, O'Carroll RE, Austin MP, Ebmeier KP, Goodwin GM. A single photon emission computerised tomography study of regional brain function in elderly patients with major depression and with alzheimer-type dementia. Br J Psychiatry 1993, 163:155-165. 10.1192/bjp.163.2.155, 8075905.